RadNet, Inc. (RDNT) Guidance & Earnings Results

On 2026-08-10 RadNet, Inc. raised guidance: "FY2026 Imaging Center guidance raised for Revenue, Adjusted EBITDA, and Free Cash Flow; Digital Health guidance…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

RDNTRadNet, Inc.Follow RDNT — free

Diagnostics & Research · Healthcare

—

Price chart with a free account

Market cap: 5.5B
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 5 Nov, in 12 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
10 Aug 26	Raised	FY2026 Imaging Center guidance raised for Revenue, Adjusted EBITDA, and Free Cash Flow; Digital Health guidance reaffirmed · full year
11 May 26	Raised	Increased 2026 Imaging Center guidance for Revenue, Adjusted EBITDA and Free Cash Flow; reaffirmed all Digital Health guidance ranges · full year
2 Mar 26	Raised	Imaging Center Revenue growth 17-19%; Adjusted EBITDA growth 18-22%; Free Cash Flow growth 29-41%; Digital Health Revenue growth 46-56%
10 Nov 25	Raised	Increased Imaging Center Revenue and Adjusted EBITDA ranges; raised Digital Health Revenue guidance · full year
11 Aug 25	Raised	Full-year 2025 Revenue and Adjusted EBITDA guidance raised. Specific revised ranges not provided in excerpt. · full year

RadNet, Inc. — questions

What guidance did RadNet, Inc. give?: On 2026-08-10: "FY2026 Imaging Center guidance raised for Revenue, Adjusted EBITDA, and Free Cash Flow; Digital Health guidance reaffirmed"
When does RadNet, Inc. report earnings?: RadNet, Inc.'s next earnings report is expected on 2026-11-05.

Every figure on this page comes from RadNet, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.